Back
Apellis Pharmaceuticals, Inc. Stock Predictions
Know when to buy, sell, or hold. Rate Any Stock In Seconds
Get Your Free Stock Analysis Now
Sell
45
APLS
Apellis Pharmaceuticals, Inc.
Last Price:
$23.07
Seasonality Move:
10.16%
7 Day Trial
ALL ACCESS PASS
$
7
Color-coded buy, sell, hold signals make stock decisions simple.
Get Your Free Stock Analysis NowApellis Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, Apellis Pharmaceuticals, Inc. has on average historically risen by 20.4% based on the past 8 years of stock performance.
-
Apellis Pharmaceuticals, Inc. has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Apellis Pharmaceuticals, Inc. Stock Undervalued?The current Apellis Pharmaceuticals, Inc. [APLS] share price is $23.07. The Score for APLS is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Apellis Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Apellis Pharmaceuticals, Inc. has on average historically risen by 20.4% based on the past 8 years of stock performance.
Apellis Pharmaceuticals, Inc. Stock Rating
Sell
45
Apellis Pharmaceuticals, Inc. (APLS)
is a Sell
Is Apellis Pharmaceuticals, Inc. overpriced?
-
Apellis Pharmaceuticals, Inc. has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Apellis Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
apellis.com
52-Week Data
52-Week High:
30.60
52-Week Low:
16.10
Prediction Charts
Market Cap:
2.9B
Price in USD:
23.07
Volume:
5.7M
Beta:
0.87
Technical Analysis
SMA50:
22.81
SMA100:
23.52
SMA200:
21.91
52-Wk Change:
-21.21%
Stock Predictions
-
Is Apellis Pharmaceuticals, Inc. stock public?Yes, Apellis Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Apellis Pharmaceuticals, Inc. stock quote today?The Apellis Pharmaceuticals, Inc. stock price is 23.07 USD today.
-
How to buy Apellis Pharmaceuticals, Inc. stock online?You can buy Apellis Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-8 | 26.23 | 26.26 | 26.44 | 25.77 |
| Jan-9 | 26.60 | 27.30 | 27.46 | 26.19 |
| Jan-12 | 26.41 | 23.20 | 26.55 | 22.37 |
| Jan-13 | 22.81 | 21.33 | 23.09 | 21.13 |
| Jan-14 | 21.29 | 20.33 | 21.29 | 20.03 |
| Jan-15 | 20.47 | 20.53 | 20.59 | 20.04 |
| Jan-16 | 20.53 | 19.94 | 20.70 | 19.76 |
| Jan-20 | 19.65 | 20.47 | 20.52 | 19.26 |
| Jan-21 | 21.64 | 20.95 | 21.69 | 20.69 |
| Jan-22 | 20.95 | 22.00 | 22.24 | 20.95 |
| Jan-23 | 21.78 | 21.75 | 22.14 | 21.42 |
| Jan-26 | 21.59 | 21.99 | 22.11 | 21.30 |
| Jan-27 | 21.95 | 21.81 | 22.09 | 21.10 |
| Jan-28 | 22.44 | 23.07 | 23.79 | 22.14 |
Apellis Pharmaceuticals, Inc. Earnings
Apellis Pharmaceuticals, Inc. Earnings Report: Per Share Apellis Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Apellis Pharmaceuticals, Inc. Forecast Revenue Growth
Apellis Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Apellis Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $1.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.57 per share, and an increase next year of $0.89 per share.
* Apellis Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.